Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
Br J Dermatol ; 176(2): 378-386, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27373553

ABSTRACT

BACKGROUND: A multidrug regimen including isoniazid, rifampicin, pyrazinamide and ethambutol is commonly used as first-line treatment for tuberculosis. However, this regimen can occasionally result in severe adverse drug reactions, such as drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and drug-induced liver injury. The culprit drug and mechanistic basis for the hypersensitive reaction are unknown. OBJECTIVES: To investigate drug-specific T-cell responses in patients with antituberculosis drug (ATD)-induced cutaneous hypersensitivity and its underlying mechanism. METHODS: We enrolled eight patients with ATD-induced maculopapular exanthema and DRESS and performed a lymphocyte transformation test. Subsequently, drug-specific T-cell clones were generated from four of the patients who showed proliferation in response to ATDs. We measured the drug-specific proliferative responses and counted the drug-specific interferon (IFN)-γ/granzyme B-producing cells after drug stimulation. Antihuman leukocyte antigen (HLA) class I and class II blocking antibodies were used to analyse human leukocyte antigen-restricted T-cell responses. RESULTS: Positive proliferative responses to ATDs were mostly found in patients with cutaneous hypersensitivity. Furthermore, we isolated isoniazid/rifampicin-specific T cells from patients, which consisted primarily of CD4+ T cells. Drug-specific CD4+ T cells proliferated and secreted IFN-γ/granzyme B when stimulated with isoniazid or rifampicin, respectively. Isoniazid-responsive T-cell clones did not proliferate in the presence of rifampicin and vice versa. Drug-specific T-cell responses were blocked in the presence of anti-HLA class II antibodies. CONCLUSIONS: This study identifies the presence of isoniazid/rifampicin-specific T cells in patients with ATD-induced maculopapular exanthema and DRESS. Furthermore, it highlights the important role of drug-specific T-cell immune responses in the pathogenesis of these reactions.


Subject(s)
Antitubercular Agents/adverse effects , CD4-Positive T-Lymphocytes/immunology , Drug Hypersensitivity Syndrome/immunology , Exanthema/chemically induced , Immunity, Cellular/immunology , Adult , Antitubercular Agents/immunology , Exanthema/immunology , Female , HLA Antigens/drug effects , HLA Antigens/immunology , Humans , Isoniazid/adverse effects , Isoniazid/immunology , Male , Middle Aged , Rifampin/adverse effects , Rifampin/immunology
2.
Int J Tuberc Lung Dis ; 19(6): 702-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25946363

ABSTRACT

OBJECTIVE: To investigate the effect of interleukin (IL) 27 -964A/G, 2095T/G, 4603G/A and 4730T/C gene polymorphisms on the development of pulmonary tuberculosis (PTB), radiographic characteristics and severity. DESIGN: Differences in the allele and genotype distributions of the -964A/G, 2095T/G, 4603G/A and 4730T/C polymorphisms between 224 PTB patients and 233 healthy controls, between patients with single- and multi-lobe involvement, and between patients with and without cavitation, were investigated. Serum IL-27 concentration was measured using an enzyme-linked immunosorbent assay. RESULTS: There were no significant differences in the allele or genotype distributions between PTB patients and healthy controls. However, the -964A/A genotype was more prevalent in patients with single-lobe involvement than the -964A/G or -964G/G genotype in patients with multi-lobe involvement (50.0% vs. 31.3%, P = 0.01). There was no difference between patients with and without cavitation (P > 0.05). Serum median IL-27 concentration was significantly higher in patients with single-lobe involvement than in those with multi-lobe involvement (P = 0.03) and in those with -964A/A genotypes than in those with -964A/G or -964G/G genotypes (P = 0.02). CONCLUSIONS: In terms of serum IL-27 levels, the -964 A/A genotype may be associated with a protective role that prevents the intrapulmonary spread of PTB rather than its development.


Subject(s)
Interleukins/genetics , Polymorphism, Single Nucleotide , Tuberculosis, Pulmonary/genetics , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Female , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Humans , Interleukins/blood , Lung/diagnostic imaging , Lung/microbiology , Male , Middle Aged , Phenotype , Predictive Value of Tests , Protective Factors , Radiography , Risk Factors , Severity of Illness Index , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology , Young Adult
3.
Scand J Surg ; 104(2): 108-14, 2015 Jun.
Article in English | MEDLINE | ID: mdl-24809357

ABSTRACT

BACKGROUND AND AIMS: Electrical burns are uncommon, but they result in high morbidity and mortality due to severe tissue damage. The purpose of this study is to analyze epidemiological variables of electrical injuries and identify preventable measures through them. MATERIAL AND METHODS: We retrospectively analyzed the clinical records of 625 patients admitted to Hangang Sacred Heart Hospital's Department of Plastic Surgery from January 2005 to December 2011. We divided the patients into two groups: (1) low-voltage injury (under 1000 V) and (2) high-voltage injury (over 1000 V). We reviewed the following variables: age, sex, total burn surface area, injury type and mode, and surgical modalities. RESULTS AND CONCLUSIONS: The mean age of all patients was 33.4 ± 18.2 years. The ratio of males to females was 13.5 in the whole group. The mean total body surface are burned was 14.0% ± 13.8% in total. The majority of electrical burns in the low-tension group and high-tension group occurred in patients under 20 years and in patients aged 40-59 years, respectively. Steel chopstick insertions and high-voltage electrical work/repair were the most common injury modes in the low-tension group and the high-tension group, respectively. Groin and abdominal distant flap surgeries were commonly performed in both groups. It is recommended that these risks be prevented through education and safety measures to reduce the incidence of electrical injuries.


Subject(s)
Burns, Electric/epidemiology , Plastic Surgery Procedures/methods , Surgical Flaps , Adolescent , Adult , Aged , Burns, Electric/diagnosis , Burns, Electric/surgery , Child , Child, Preschool , Female , Humans , Incidence , Male , Middle Aged , Republic of Korea/epidemiology , Retrospective Studies , Survival Rate/trends , Trauma Severity Indices , Young Adult
4.
J Appl Microbiol ; 116(5): 1334-43, 2014 May.
Article in English | MEDLINE | ID: mdl-24471528

ABSTRACT

AIMS: Inhalational anthrax is caused by the entry of Bacillus anthracis spores into the lung. Inhaled spores are phagocytosed by alveolar macrophages. Bacilli then escape from the macrophage and spread to other cells, initiating a systemic anthrax infection. Based on the pathological studies of primate and human inhalational anthrax cases, it appears that lung tissue injury is a lethal consequence of the disease. Although the cytotoxicity of anthrax lethal toxin to macrophages is well known, it is not clear how anthrax toxin affects the various lung cell types. METHODS AND RESULTS: Using model cell lines representing different physiological compartments of the lung, we have investigated the cytotoxic effects of anthrax lethal toxin. The cell response was evaluated through MTT metabolism, neutral red uptake, initiation of apoptosis, and expression and binding activity of anthrax toxin receptors. We found that a human small airway epithelial cell line, HSAEC, was susceptible to anthrax lethal toxin. The other cell lines, A549, MRC-5, H358 and SKLU-1, displayed resistance to anthrax lethal toxin-mediated toxicity, although the expression of anthrax toxin receptors was detected in all the cell lines tested. CONCLUSIONS: Our results indicate that cell-type-specific toxicity may be induced by anthrax lethal toxin in human lung tissues and does not correlate with anthrax toxin receptor expression levels. SIGNIFICANCE AND IMPACT OF THE STUDY: This work suggests that cell-type-specific cytotoxicity of anthrax toxin in lung cells may cause subsequent lung disease progression. It may explain the initial pathogenic step of inhalational anthrax.


Subject(s)
Antigens, Bacterial/toxicity , Bacterial Toxins/toxicity , Lung/drug effects , Animals , Apoptosis , Cell Line , Cytotoxins/toxicity , Humans , Lung/cytology , Lung/metabolism , Receptors, Peptide/metabolism
5.
Clin Exp Dermatol ; 37(7): 722-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22731761

ABSTRACT

BACKGROUND: Chronic urticaria (CU) is a common skin disorder that affects the well-being and quality of life (QOL) of patients. Recently, we developed and validated a questionnaire for measuring QOL in Korean patients with CU, called the Chronic Urticaria-Specific Quality of Life (CU-QOL) questionnaire. AIM: To evaluate the clinical significance of a computerized version of the CU-QOL, in adult patients with CU. METHODS: This was a cross-sectional observational study that enrolled 249 Korean patients with CU from five university hospitals and measured computerized CU-QOL scores and Urticaria Activity Score (UAS) simultaneously. The internal consistency of the computerized CU-QOL was analysed using Cronbach α. To identify clinical correlations between the CU-QOL and patient characteristics, the atopic status and serum autoantibodies, including antinuclear, antithyroglobulin and antimicrosome antibodies, were measured. Multiple linear regression models were used to identify CU-QOL predictors. RESULTS: Cronbach α was 0.94 for the overall computerized CU-QOL score. The CU-QOL scores correlated significantly with the UAS (r= -0.49, P<0.001). Of the factors aggravating CU, delayed pressure, sunlight exposure and emotional stress significantly influenced the overall CU-QOL scores in the univariate analysis. Multivariate regression models indicated that UAS and emotional stress were significant predictors of the four domains and of the total CU-QOL scores. CONCLUSIONS: The computerized CU-QOL is a convenient and valid tool for measuring QOL in patients with CU. This study suggests that UAS, dermatographism and emotional stress are strong CU-QOL predictors in Korean patients with CU.


Subject(s)
Psychometrics/methods , Quality of Life , Software Validation , Surveys and Questionnaires/standards , Urticaria/psychology , Adolescent , Adult , Aged , Aged, 80 and over , Autoantibodies/analysis , Chronic Disease , Cross-Sectional Studies , Female , Health Status , Humans , Korea , Male , Middle Aged , Regression Analysis , Urticaria/immunology , Young Adult
6.
Int J Tuberc Lung Dis ; 15(9): 1265-70, i, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21943856

ABSTRACT

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with systemic inflammation. OBJECTIVE: To evaluate carotid artery intima-media thickness (IMT), high sensitivity C-reactive protein (hsCRP) and their correlation in newly diagnosed untreated patients with COPD. DESIGN: Post-bronchodilator spirometry, carotid artery IMT and blood tests were measured in patients with COPD (COPD group). Age, sex, body mass index, smoking status and smoking amount were compared with matched healthy subjects (non-COPD group). Participants taking medications and/or with a history of hypertension, diabetes mellitus, dyslipidaemia, COPD or cardiovascular disease were excluded. RESULTS: A total of 126 patients (COPD group 42, non-COPD group 84) were enrolled. The IMT and hsCRP of the COPD group were significantly higher than in the non-COPD group (P < 0.05). The decrease in the forced expiratory volume in 1 second/forced vital capacity (FEV(1)/FVC) ratio and FEV(1) was significantly correlated with an increase in the hsCRP and IMT (P < 0.05); there was no correlation between the IMT and hsCRP (P = 0.152). CONCLUSION: In newly diagnosed untreated patients with COPD, the carotid artery IMT and hsCRP were significantly higher than in healthy subjects. These findings suggest that systemic inflammation may play a potential role in preclinical atherosclerosis in COPD.


Subject(s)
C-Reactive Protein/metabolism , Carotid Artery Diseases/etiology , Inflammation/etiology , Pulmonary Disease, Chronic Obstructive/complications , Aged , Carotid Arteries/pathology , Carotid Artery Diseases/epidemiology , Carotid Artery Diseases/pathology , Case-Control Studies , Cohort Studies , Female , Forced Expiratory Volume , Humans , Inflammation/epidemiology , Inflammation/pathology , Male , Middle Aged , Prospective Studies , Tunica Intima/pathology , Tunica Media/pathology
7.
Cell Death Differ ; 17(12): 1830-41, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20448643

ABSTRACT

The zinc-finger protein A20 has crucial physiological functions as a dual inhibitor of nuclear factor-κB (NF-κB) activation and apoptosis in tumor necrosis factor (TNF) receptor 1 signaling pathway. Although the molecular basis for the anti-NF-κB function of A20 has been well elucidated, the anti-apoptotic function of A20 is largely unknown. Here, we report a novel mechanism underlying the anti-apoptotic function of A20: A20 blocks TNF-induced apoptosis through suppression of c-jun N-terminal kinase (JNK) by targeting apoptosis signal-regulating kinase1 (ASK1). First, the ectopic expression of A20 drastically inhibits TNF-induced JNK activation and apoptosis in multiple cell types including those deficient of NF-κB activation. Unexpectedly, the blunting effect of A20 on TNF-induced JNK activation is not mediated by affecting the TNFR1 signaling complex formation. Instead, A20 interacts with ASK1, an important MAPKK kinase in the JNK signaling cascade. More importantly, overexpression of wild-type A20, but not of mutant A20 (ZnF4; C624A, C627A), promotes degradation of the ASK1 through the ubiquitin-proteasome system. Taken together, the results from this study reveal a novel anti-apoptotic mechanism of A20 in TNF signaling pathway: A20 binds to ASK1 and mediates ASK1 degradation, leading to suppression of JNK activation and eventually blockage of apoptosis.


Subject(s)
Apoptosis , Intracellular Signaling Peptides and Proteins/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , MAP Kinase Kinase Kinase 5/metabolism , Nuclear Proteins/metabolism , Tumor Necrosis Factor-alpha/metabolism , Cell Line, Tumor , DNA-Binding Proteins , Humans , NF-kappa B/metabolism , Receptors, Tumor Necrosis Factor, Type I/metabolism , Signal Transduction , TNF Receptor-Associated Factor 2/metabolism , Tumor Necrosis Factor alpha-Induced Protein 3 , Ubiquitination
8.
Clin Exp Immunol ; 161(2): 298-305, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20491794

ABSTRACT

Statins are potent inhibitors of hydroxyl-3-methylglutaryl co-enzyme A (HMG-CoA) reductase, and have emerged as potential anti-cancer agents based on preclinical evidence. In particular, compelling evidence suggests that statins have a wide range of immunomodulatory properties. However, little is known about the role of statins in tumour immune tolerance. Tumour immune tolerance involves the production of immunosuppressive molecules, such as interleukin (IL)-10, transforming growth factor (TGF)-beta and indoleamine-2,3-dioxygenase (IDO) by tumours, which induce a regulatory T cell (T(reg)) response. In this study, we investigated the effect of simvastatin on the production of IL-10, TGF-beta and IDO production and the proliferation of T(regs) using several cancer cell lines, and Lewis lung cancer (3LL) cells-inoculated mouse tumour model. Simvastatin treatment resulted in a decrease in the number of cancer cells (3LL, A549 and NCI-H292). The production of the immune regulatory markers IL-10, TGF-beta in 3LL and NCI-H292 cells increased after treatment with simvastatin. The expression of IDO and forkhead box P3 (FoxP3) transcription factor was also increased in the presence of simvastatin. In a murine 3LL model, there were no significant differences in tumour growth rate between untreated and simvastatin-treated mice groups. Therefore, while simvastatin had an anti-proliferative effect, it also exhibited immune tolerance-promoting properties during tumour development. Thus, due to these opposing actions, simvastatin had no net effect on tumour growth.


Subject(s)
Immune Tolerance/drug effects , Neoplasms/immunology , Simvastatin/pharmacology , T-Lymphocytes, Regulatory/drug effects , Animals , Cell Count , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cyclin D1/metabolism , Cytostatic Agents/pharmacology , Cytostatic Agents/therapeutic use , Forkhead Transcription Factors/genetics , Gene Expression/drug effects , Gene Expression/genetics , Humans , Immune Tolerance/immunology , Immunosuppressive Agents/pharmacology , Immunosuppressive Agents/therapeutic use , Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics , Interleukin-10/metabolism , Interleukin-2 Receptor alpha Subunit/metabolism , Mice , Mice, Inbred C57BL , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Simvastatin/therapeutic use , Spleen/cytology , Spleen/immunology , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Transforming Growth Factor beta/metabolism
9.
Br J Cancer ; 102(4): 710-8, 2010 Feb 16.
Article in English | MEDLINE | ID: mdl-20087351

ABSTRACT

BACKGROUND: Stathmin1 is a microtubule-regulating protein that has an important role in the assembly and disassembly of the mitotic spindle. The roles of stathmin1 in carcinogenesis of various cancers, including prostate and breast cancer, have been explored. However, its expression and roles in gastric cancer have not yet been described. METHODS: Stathmin1 expression in paraffin-embedded tissue sections from 226 patients was analysed by immunohistochemistry. Roles of stathmin1 were studied using a specific small interfering RNA (siRNA). RESULTS: The expression of stathmin1 was positively correlated with lymph node metastasis, TNM stages and vascular invasion, and negatively with recurrence-free survival, in the diffuse type of gastric cancer. The median recurrence-free survival in patients with a negative and positive expression of stathmin1 was 17.0 and 7.0 months, respectively (P=0.009). When the expression of stathmin1 was knocked down using siRNA, the proliferation, migration and invasion of poorly differentiated gastric cancer cells in vitro were significantly inhibited. Moreover, stathmin1 siRNA transfection significantly slowed the growth of xenografts in nude mice. CONCLUSION: These results suggest that stathmin1 can be a good prognostic factor for recurrence-free survival rate and is a therapeutic target in diffuse-type gastric cancer.


Subject(s)
Carcinoma/genetics , Cell Movement/genetics , Cell Proliferation , Stathmin/genetics , Stomach Neoplasms/genetics , Aged , Animals , Carcinoma/metabolism , Carcinoma/mortality , Carcinoma/pathology , Case-Control Studies , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Male , Mice , Mice, Nude , Middle Aged , Neoplasm Invasiveness , RNA, Small Interfering/pharmacology , Stathmin/antagonists & inhibitors , Stathmin/metabolism , Stomach Neoplasms/metabolism , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Up-Regulation/drug effects , Xenograft Model Antitumor Assays
11.
Clin Exp Allergy ; 39(5): 655-61, 2009 May.
Article in English | MEDLINE | ID: mdl-19236408

ABSTRACT

BACKGROUND: Increased vessel number and permeability are important features of the nasal mucosa in allergic rhinitis (AR), and are mediated in part by the cytokine vascular endothelial growth factor (VEGF). Eosinophils are the major effector cells in the nasal secretions of patients with AR during the responses to allergen challenges. To evaluate the involvement of VEGF in nasal allergic inflammation, we monitored the levels of VEGF, eosinophil cationic protein (ECP), and specific antibodies in the nasal lavage fluids (NLFs) of patients with AR in response to Dermatophagoides pteronyssinus (Dpt). METHODS: Sixty-three subjects with sensitization to Dpt were enrolled: 29 patients with AR (group I) who showed positive responses in a nasal provocation test (NPT) with Dpt; and 34 asymptomatic controls (group II) who showed sensitization to Dpt but negative NPT results. NLF samples were collected at baseline, 10, 30, and 60 min, and at 3, 6, and 24 h during the NPT. The ECP levels in the NLF samples were measured using the ImmunoCAP system. VEGF and Dpt-specific IgE, IgA, and IgG in the NLF samples were detected by ELISA. RESULTS: The eosinophil counts and ECP levels in the samples were significantly increased in group I, but not in group II, during the early and late responses. Although the baseline VEGF level was not significantly different between groups I and II, increased VEGF production was noted in group I after the NPT, especially during the early response. The level of Dpt-specific IgA was significantly increased in group I during the NPT. A relationship was found between the levels of VEGF and ECP or Dpt-specific IgA in the NLF samples collected at 10 min and at 3-6 h (P<0.05, respectively). CONCLUSION: Nasal VEGF secretion in response to allergen exposure may augment eosinophilic inflammation in the nasal mucosa of patients with AR.


Subject(s)
Eosinophil Cationic Protein/metabolism , Eosinophils/immunology , Rhinitis, Allergic, Perennial/immunology , Rhinitis, Allergic, Seasonal/immunology , Vascular Endothelial Growth Factor A/metabolism , Adult , Allergens/immunology , Animals , Antigens, Dermatophagoides/immunology , Dermatophagoides pteronyssinus/immunology , Eosinophil Cationic Protein/immunology , Eosinophils/metabolism , Female , Humans , Immunoglobulin A/immunology , Immunoglobulin A/metabolism , Immunoglobulin E/immunology , Immunoglobulin E/metabolism , Immunoglobulin G/immunology , Immunoglobulin G/metabolism , Male , Nasal Lavage Fluid/immunology , Nasal Provocation Tests , Rhinitis, Allergic, Perennial/metabolism , Rhinitis, Allergic, Seasonal/metabolism , Vascular Endothelial Growth Factor A/immunology
12.
Allergy ; 64(2): 213-21, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19178400

ABSTRACT

BACKGROUND: Histamine plays an important role in allergic inflammation. Histamine levels are regulated by histamine N-methyltransferase (HNMT). OBJECTIVE: To investigate the functional variability of HNMT gene in relation to genetic polymorphisms in patients with aspirin intolerant chronic urticaria (AICU). METHODS: Two single-nucleotide polymorphisms of the HNMT gene (314C>T, 939A>G) were genotyped in chronic urticaria patients. The functional variability of 3'-untranslated region polymorphism (3'-UTR) was assessed using the pEGFP-HNMT 3'-UTR reporter construct to examine mRNA stability and fluorescence-tagged protein expression. The HNMT enzymatic activities related to the 939A>G polymorphism were examined both in the human mast cells (HMC-1) transfected with the pHNMT CDS-3'-UTR construct and in the patients' red blood cells (RBCs). Histamine release from the basophils of AICU patients was examined. RESULTS: The 939A>G polymorphism was significantly associated with the AICU phenotype, while no association was found with the 314C>T polymorphism. An in vitro functional study using HMC-1 cells demonstrated that the 939A allele gave lower levels of HNMT mRNA stability, HNMT protein expression, and HNMT enzymatic activity and higher histamine release than the 939G allele. The in vivo functional study demonstrated that the AICU patients with the 939A allele had lower HNMT activity in RBC lysates and higher histamine release from their basophils. CONCLUSION: The HNMT 939A>G polymorphism lowers HNMT enzymatic activity by decreasing HNMT mRNA stability, which leads to an increase in the histamine level and contributes to the development of AICU.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Histamine N-Methyltransferase/genetics , RNA Stability/genetics , Urticaria/genetics , Adult , Alleles , Anti-Inflammatory Agents, Non-Steroidal/immunology , Aspirin/immunology , Basophils/immunology , Basophils/metabolism , Case-Control Studies , Chronic Disease , Erythrocytes/immunology , Erythrocytes/metabolism , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Histamine N-Methyltransferase/immunology , Histamine N-Methyltransferase/metabolism , Histamine Release/genetics , Histamine Release/immunology , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Urticaria/drug therapy , Urticaria/immunology
13.
Phys Rev E Stat Nonlin Soft Matter Phys ; 78(3 Pt 2): 037201, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18851192

ABSTRACT

We study a quasibound state of a delta -kicked rotor with absorbing boundaries focusing on the nature of the dynamical localization in open quantum systems. The localization lengths xi of lossy quasibound states located near the absorbing boundaries decrease as they approach the boundary while the corresponding decay rates Gamma are dramatically enhanced. We find the relation xi approximately Gamma(-1/2) and explain it based upon the finite time diffusion, which can also be applied to a random unitary operator model. We conjecture that this idea is valid for the system exhibiting both the diffusion in classical dynamics and the exponential localization in quantum mechanics.

15.
Clin Exp Allergy ; 38(4): 586-93, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18352975

ABSTRACT

BACKGROUND: Although methylene diphenyl diisocyanate (MDI) is widely used in many industries, there have been few immunological studies of MDI-induced occupational asthma. OBJECTIVES: We investigated the effects of MDI exposure on the clinical and immunologic condition of workers in a single car upholstery factory. METHODS: Fifty-eight MDI-exposed workers were studied. Work-related lower-respiratory symptoms (WRRS) were identified using a questionnaire. Serum-specific IgE and IgG antibodies to MDI-human serum albumin conjugate were detected by ELISA. Atopy was evaluated using a skin prick test. MDI-induced occupational asthma was confirmed in the symptomatic workers with a positive result on an MDI-specific inhalation test. RESULTS: Thirteen (22.4%) of the subjects complained of WRRS. MDI-induced occupational asthma was confirmed in five (8.6%) of the workers, and occupational eosinophilic bronchitis was confirmed in two (3.5%). The prevalence of specific IgG antibodies (20.7%) was higher than that of specific IgE antibodies (8.6%). The prevalence of MDI-induced occupational asthma/eosinophilic bronchitis was strongly associated with the presence of both WRRS and serum-specific IgG antibodies to an MDI-human serum albumin conjugate (P<0.01, <0.05, respectively). CONCLUSION: These findings suggest that MDI could be a causative agent of occupational asthma among MDI-exposed workers. The prevalence of MDI-induced occupational asthma was 8.6%, and MDI-induced eosinophilic bronchitis was confirmed in two workers. The presence of work-related lower-respiratory symptoms and serum-specific IgG antibodies to an MDI-human serum albumin conjugate may be used to predict MDI-induced occupational asthma/eosinophilic bronchitis in MDI-exposed workers.


Subject(s)
Asthma/immunology , Automobiles , Isocyanates/adverse effects , Occupational Diseases/immunology , Occupational Exposure/adverse effects , Adult , Antibodies/immunology , Asthma/chemically induced , Environmental Monitoring , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin E/immunology , Immunoglobulin G/immunology , Korea , Male , Middle Aged , Occupational Diseases/chemically induced , Occupational Diseases/diagnosis , Predictive Value of Tests , Prevalence , Reproducibility of Results , Respiratory Tract Diseases/chemically induced , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/immunology , Serum Albumin/immunology , Skin Tests , Spirometry , Surveys and Questionnaires
16.
Rheumatology (Oxford) ; 47(3): 301-8, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18276737

ABSTRACT

OBJECTIVE: Resveratrol is a naturally occurring polyphenol, which possesses chemotherapeutic potential through its ability to trigger apoptosis. The objective of this study was to investigate the major determinant for the apoptotic cell death induction by resveratrol in fibroblast-like synoviocytes (FLS) derived from patients with RA. METHODS: The effect of resveratrol on apoptotic cell death was quantified in a population of subG1 in RA FLS by flow cytometry. The underlying signalling mechanism for apoptotic death was examined by analysing mitochondrial membrane potential, activation of the caspase cascade and translocation of Bid. RESULTS: We show that activation of caspase-8 is essential for triggering resveratrol-induced apoptotic signalling via the involvement of the mitochondrial pathway in RA FLS. Our findings also suggest that this enhanced apoptosis caused by resveratrol occurred in RA FLS irrespective of p53 status. Exposure to resveratrol caused extensive apoptotic cell death, along with a caspase-dependent (activation of caspase-9 and -3, poly ADPribose polymerase (PARP) cleavage and mitochondrial cytochrome c release) or caspase-independent [translocation of apoptosis-inducing factor (AIF) to the nucleus] signalling pathway. Analysis of upstream signalling events affected by resveratrol revealed that the activated caspase-8 triggered mitochondrial apoptotic events by inducing Bid cleavage without any alteration in the levels of Bax, Bcl-xL or Bcl2. The caspase-8 inhibitor or over-expression of crmA abrogated cell death induced by resveratrol and prevented processing of the downstream cascade. CONCLUSION: The results suggest that resveratrol causes activation of caspase-8, which in turn results in modulation of mitochondrial apoptotic machinery to promote apoptosis of RA FLS.


Subject(s)
Apoptosis Inducing Factor/metabolism , Apoptosis/drug effects , Arthritis, Rheumatoid/physiopathology , Caspase 8/metabolism , Stilbenes/pharmacology , Apoptosis Inducing Factor/drug effects , Arthritis, Rheumatoid/metabolism , Caspase 8/drug effects , Cells, Cultured , Fibroblasts/cytology , Fibroblasts/drug effects , Fluorescent Antibody Technique , Humans , Membrane Potentials , Mitochondria/physiology , Probability , Resveratrol , Sensitivity and Specificity , Synovial Membrane/cytology , Synovial Membrane/drug effects
17.
J Clin Pharm Ther ; 33(6): 691-7, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19138248

ABSTRACT

BACKGROUND: Chronic urticaria/angioedema is a common phenotype in patients with aspirin sensitivity; however, its genetic mechanism is not understood. Transforming growth factor (TGF)beta1 is a key regulatory cytokine involved in allergic inflammation. OBJECTIVE: We examined the association of a TGFbeta1 genetic polymorphism with aspirin-intolerant chronic urticaria (AICU) and aspirin-tolerant chronic urticaria (ATCU) in a Korean population. METHODS: A promoter polymorphism in the TGFbeta1 gene, TGFbeta1 -509C>T, was analysed in 112 AICU patients, 153 ATCU patients and 457 normal controls (NC), and the frequency was compared among the groups. Serum TGFbeta1 levels were measured by ELISA. RESULTS: The minor allele frequency of the -509C>T polymorphism was significantly higher in patients with AICU compared with the other two groups (P < 0.02 for AICU vs. NC; P < 0.05 for AICU vs. ATCU). Among the AICU patients, those with the T allele tended to have lower serum TGFbeta1 levels. CONCLUSION: These findings suggest that the -509C>T polymorphism in the TGFbeta1 promoter may contribute to the development of the AICU phenotype.


Subject(s)
Aspirin/adverse effects , Drug Hypersensitivity/genetics , Polymorphism, Genetic , Transforming Growth Factor beta1/genetics , Adult , Alleles , Angioedema/chemically induced , Angioedema/genetics , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Enzyme-Linked Immunosorbent Assay , Female , Gene Frequency , Humans , Korea/epidemiology , Male , Middle Aged , Phenotype , Promoter Regions, Genetic , Urticaria/chemically induced , Urticaria/genetics , Young Adult
19.
Br J Dermatol ; 154(5): 829-38, 2006 May.
Article in English | MEDLINE | ID: mdl-16634882

ABSTRACT

BACKGROUND: Radiation induces many cellular events leading to radiodermatitis. OBJECTIVES: The aim of this study was to establish a radiodermatitis model using experimental animals, and to examine the expression profile of radiation-induced genes. METHODS: Hairless mice were irradiated on the dorsal skin; then total RNAs were isolated and microarray hybridizations were performed. RESULTS: Irradiation with a total of 40 Gy (10 Gy day-1 for four consecutive days) provokes radiodermatitis in the hairless mouse. After microarray analysis, 130 genes that showed upregulation by radiation were selected and organized into four different clusters, depending on the time-kinetic pattern. Classification of these genes into several functional categories revealed that various biological processes were globally affected by radiation. These include transcription regulation, signal transduction, cell communication, cell death regulation and metabolism. CONCLUSIONS: These results demonstrate the complexity of the transcriptional profile of the radiation response, providing important clues on which to base further investigations of the molecular events underlying radiodermatitis.


Subject(s)
Disease Models, Animal , Radiodermatitis/genetics , Animals , Dose-Response Relationship, Radiation , Gene Expression Profiling , Male , Mice , Mice, Hairless , Microarray Analysis , Multigene Family , Polymerase Chain Reaction/methods , Radiodermatitis/etiology , Up-Regulation/radiation effects , Weight Loss/radiation effects
20.
Abdom Imaging ; 31(4): 433-8, 2006.
Article in English | MEDLINE | ID: mdl-16465567

ABSTRACT

BACKGROUND: We evaluated the clinical efficacy and technical feasibility of the percutaneously inserted self-expandable nitinol stent (Zilver stent) for palliation of malignant biliary obstruction. METHODS: Seventeen patients with malignant tumors involving the intra- or extrahepatic bile duct who presented with obstructive jaundice underwent percutaneous insertion of a self-expandable nitinol stent. We retrospectively reviewed the hospital records of patients and evaluated the technical feasibility on stent placement, complications, patient survival, and duration of stent patency. RESULTS: Percutaneous biliary stenting with 27 Zilver stents was performed in 17 patients with malignant biliary obstruction. Technical success was 95%. Malposition of the stent was encountered in one patient. Minor technical problems were encountered in two patients: the introducer tip was broken during stent insertion, so endoscopic removal was done. Mean follow-up period for the 17 patients was 182 days (range 29-485 days): nine patients died of progressive disease at a mean follow-up of 151 days (range 61-371days) after stent insertion and eight patients remained alive at the final follow-up of 216 days (range 29-485 days). The median survival period for all patients was 277 days. The stent occlusion rate was 26% and the mean patency period was 280 days. In five patients, seven stents were obstructed by tumor ingrowth and overgrowth. Stent patency rates were 100%, 100%, 75%, 61%, and 41% at 1, 2, 3, 6, and 12 months, respectively. A late complication, erosive bleeding of the hepatic artery by the stent, developed in one patient. CONCLUSION: Percutaneous biliary stenting using the nitinol stent is technically feasible and safe and clinically efficacious treatment for malignant biliary obstruction, even with a minor technical problem during stent insertion.


Subject(s)
Bile Duct Neoplasms/complications , Cholestasis/therapy , Stents , Aged , Aged, 80 and over , Alloys , Bile Duct Neoplasms/mortality , Cholestasis/etiology , Feasibility Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Stents/adverse effects , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...